Insmed, Inc. (INSM) Reports Q3 Loss of $1.39, Sales Fall Y/Y
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Join SI Premium – FREE
Insmed, Inc. (NASDAQ: INSM) reported Q3 EPS of ($1.39), versus ($0.03) reported last year. Revenue for the quarter came in at $400 thousand, versus $1.8 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Insmed (INSM) PT Lowered to $201 at Guggenheim
- Performance Food Group (PFGC) Tops Q1 EPS by 2c, Misses on Revenue; Offers FY27 Revenue Guidance
- BioCryst Pharma (BCRX) Tops Q3 EPS by 5c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
